27 October 2026
Linklaters advises QIAGEN on recommended voluntary all-cash public takeover offer by EQT
Advising firms
Deal team
13 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Staffan Illert Lead | Linklaters | Partner | Corporate/M&A | Not stated |
| Prof Dr Daniela Seeliger Lead | Linklaters | Not stated | Antitrust & Foreign Investment | Not stated |
| David dos Santos Goncalves | Linklaters | Partner | Antitrust & Foreign Investment | Not stated |
| Dr Alexander Schlee | Linklaters | Not stated | Capital Markets | Not stated |
| Ben Bauer | Linklaters | Counsel | Antitrust & Foreign Investment | New York |
| Ulli Janssen | Linklaters | Counsel | Corporate/M&A | Not stated |
| Tobias Rump | Linklaters | Counsel | Antitrust & Foreign Investment | Not stated |
| Will Creswell | Linklaters | Counsel | Capital Markets | Not stated |
| Urs Lewens | Linklaters | Counsel | Banking | Not stated |
| Kevin Eisenschmidt | Linklaters | Senior associate | Corporate/M&A | Not stated |
| Catrin Retzmann | Linklaters | Senior associate | Capital Markets | Not stated |
| Kathy Choi | Linklaters | Associate | Not stated | London |
| Theresa Noßke | Linklaters | Associate | Antitrust & Foreign Investment | Not stated |
10 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- EUR 10.8bn (approx. €10.8bn)
- What the figure measures
- Enterprise value
- Client
- QIAGEN N.V.Target
- Counterparties
- EQT Private Equity (Buy-side)
Luxinva S.A. (Investor)
CPP Investment Board Europe Inc. (Investor)